No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

UVC PureLight 360​ Proven To Kill The Spread Of COVID-19 Coronavirus

Editor: What To Know

  • “UVC light is a proven method to sanitize indoor spaces from many known pathogens, and it's a critical health advancement to know that our new technology kills the spread of this deadly virus,”.
  • 2 million deaths worldwide in 2020, and the resurgence of the virus in the U.
  • UVC PureLight 360​, a new UVC induction light disinfection and sanitization technology, has passed testing that shows the technology kills the indoor spread of numerous pathogens, including COVID-19 Coronavirus.

UVC PureLight 360​, a new UVC induction light disinfection and sanitization technology, has passed testing that shows the technology kills the indoor spread of numerous pathogens, including COVID-19 Coronavirus.

UVC PureLight 360 Test results from a leading independent international laboratory confirm that the patent-pending 320W UVC Induction/LED prototype from Miami-based UVC PureLight 360 LLC inactivates more than 99.9% of COVID-19 in a 16′ X 16′ room in as little as 3.5 minutes.

COVID-19 has caused more than 1.2 million deaths worldwide in 2020, and the resurgence of the virus in the U.S. has led to more than 10 million current infections.

“UVC light is a proven method to sanitize indoor spaces from many known pathogens, and it’s a critical health advancement to know that our new technology kills the spread of this deadly virus,” said Dr. Minghsun Liu, microbiologist, infectious disease specialist, and UVC PureLight 360TM advisory board member.

The technology also kills germs and bacteria that cause common colds and flu, SARS, MERS, H1N1 and other health threats.

UVC PureLight 360​TM was developed to create safe, clean indoor spaces in a wide variety of locations such as medical facilities, hotels, offices, schools, retail, fitness centers, restaurants and more.

“When launching UVC PureLight 360, we wanted to ensure our device was an effective, tested and proven solution for all these settings,” said Alan Mandel, CEO and co-founder of UVC PureLight 360 LLC. “These verified test results prove our mission to help guests, patients and staff have peace of mind. This is a big step in overcoming the pandemic, as well as the economic hardship it has caused.”

In addition to quickly killing virulent pathogens, the UVC light leaves behind no odors or damaging residues. Currently, most businesses and facilities must spray or wipe down surfaces with harsh chemicals and other antibacterial products to remediate COVID-19.

UVC PureLight 360​TM features a hybrid UVC and LED bulb tower atop a maneuverable cart for easy room-to-room transport. The 320W output is precisely calculated to be effective against a wide range of bacteria and viruses.

The production version of the device is expected to launch in January when health officials fear COVID-19 infections will be surging. While the device is in final development, the company is aligning with distributors across the globe.

“COVID-19 has been an unprecedented public health and economic crisis,” Mandel said. “We’re proud to deliver this solution to businesses, institutions, and the public.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy